[DOI] [PubMed] [Google Scholar] 101.Vuppalanchi R., Loomba R., Sanyal A.J., Nikooie A., Tang Y., Robins D.A., Brouwers B., Hartman M.L
Res Autism Spectrum Disorders 79:101681
Key Points for Practice To reduce overall mortality in patients with type 2 diabetes mellitus, the BMJ/MAGIC Group recommends prescribing SGLT-2 inhibitors in those with cardiovascular disease and/or chronic kidney disease or three or more risk factors for cardiovascular disease
Smith K, Germain M, Williams J, et al
These check-ins allow your doctor to monitor your progress, see how youre responding to the medication, and make any necessary adjustments to your dosage
Our more-recent survey data allow us to examine whether GLP-1 use rates have changed since 2023